Jérôme Molette

530 total citations
15 papers, 279 citations indexed

About

Jérôme Molette is a scholar working on Physiology, Organic Chemistry and Cellular and Molecular Neuroscience. According to data from OpenAlex, Jérôme Molette has authored 15 papers receiving a total of 279 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Physiology, 4 papers in Organic Chemistry and 4 papers in Cellular and Molecular Neuroscience. Recurrent topics in Jérôme Molette's work include Alzheimer's disease research and treatments (7 papers), Neuroscience and Neuropharmacology Research (4 papers) and Computational Drug Discovery Methods (4 papers). Jérôme Molette is often cited by papers focused on Alzheimer's disease research and treatments (7 papers), Neuroscience and Neuropharmacology Research (4 papers) and Computational Drug Discovery Methods (4 papers). Jérôme Molette collaborates with scholars based in Switzerland, Japan and United States. Jérôme Molette's co-authors include Heiko Kroth, Francesca Capotosti, Andrea Pfeifer, André Mueller, Mathias Berndt, Felix Oden, David T. Hickman, Andrew Stephens, Ludger M. Dinkelborg and Heribert Schmitt‐Willich and has published in prestigious journals such as Journal of Medicinal Chemistry, Tetrahedron and Tetrahedron Letters.

In The Last Decade

Jérôme Molette

15 papers receiving 275 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jérôme Molette Switzerland 8 139 73 61 58 57 15 279
Daniel K. Cashion United States 4 115 0.8× 149 2.0× 97 1.6× 26 0.4× 36 0.6× 6 353
Yvan Varisco Switzerland 6 161 1.2× 28 0.4× 53 0.9× 35 0.6× 40 0.7× 7 230
Selena Milicevic Sephton United Kingdom 12 62 0.4× 68 0.9× 112 1.8× 48 0.8× 124 2.2× 30 332
Natalie Beschörner Denmark 8 159 1.1× 20 0.3× 114 1.9× 38 0.7× 44 0.8× 10 269
Kaleigh F. Roberts United States 7 214 1.5× 22 0.3× 85 1.4× 26 0.4× 42 0.7× 16 340
Akihiko Fujikawa Japan 10 94 0.7× 32 0.4× 64 1.0× 27 0.5× 35 0.6× 15 321
Hiroshi Shimadzu Japan 9 279 2.0× 77 1.1× 137 2.2× 46 0.8× 73 1.3× 17 443
Mònica Aparici Spain 14 186 1.3× 78 1.1× 141 2.3× 16 0.3× 67 1.2× 32 472
José-Ignacio Andrés Belgium 8 35 0.3× 67 0.9× 176 2.9× 16 0.3× 68 1.2× 9 302
Efthymia Vokali Sweden 5 113 0.8× 8 0.1× 36 0.6× 57 1.0× 46 0.8× 6 166

Countries citing papers authored by Jérôme Molette

Since Specialization
Citations

This map shows the geographic impact of Jérôme Molette's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jérôme Molette with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jérôme Molette more than expected).

Fields of papers citing papers by Jérôme Molette

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jérôme Molette. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jérôme Molette. The network helps show where Jérôme Molette may publish in the future.

Co-authorship network of co-authors of Jérôme Molette

This figure shows the co-authorship network connecting the top 25 collaborators of Jérôme Molette. A scholar is included among the top collaborators of Jérôme Molette based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jérôme Molette. Jérôme Molette is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Smith, Ruben, Francesca Capotosti, Martin Schain, et al.. (2022). Initial clinical scans using [18F]ACI‐12589, a novel α‐synuclein PET‐tracer. Alzheimer s & Dementia. 18(S6). 8 indexed citations
2.
Capotosti, Francesca, Efthymia Vokali, Jérôme Molette, et al.. (2022). Discovery of [18F]ACI‐12589, a Novel and Promising PET‐Tracer for Alpha‐Synuclein. Alzheimer s & Dementia. 18(S6). 4 indexed citations
3.
Kroth, Heiko, Felix Oden, Jérôme Molette, et al.. (2021). Structure-activity relationship around PI-2620 highlights the importance of the nitrogen atom position in the tricyclic core. Bioorganic & Medicinal Chemistry. 52. 116528–116528. 7 indexed citations
4.
Kroth, Heiko, Felix Oden, Jérôme Molette, et al.. (2021). PI-2620 Lead Optimization Highlights the Importance of Off-Target Assays to Develop a PET Tracer for the Detection of Pathological Aggregated Tau in Alzheimer’s Disease and Other Tauopathies. Journal of Medicinal Chemistry. 64(17). 12808–12830. 13 indexed citations
5.
Capotosti, Francesca, Efthymia Vokali, Jérôme Molette, et al.. (2021). The development of [18F]ACI‐12589, a high affinity and selective alpha‐synuclein radiotracer, as a biomarker for Parkinson’s disease and other synucleinopathies. Alzheimer s & Dementia. 17(S5). 7 indexed citations
6.
Gabellieri, Emanuele, Francesca Capotosti, Jérôme Molette, et al.. (2020). Discovery of 2-(4-(2-fluoroethoxy)piperidin-1-yl)-9-methyl-9H-pyrrolo[2,3-b:4,5-c’]dipyridine ([18F]PI-2014) as PET tracer for the detection of pathological aggregated tau in Alzheimer’s disease and other tauopathies. European Journal of Medicinal Chemistry. 204. 112615–112615. 6 indexed citations
7.
Capotosti, Francesca, Efthymia Vokali, Jérôme Molette, et al.. (2020). Developing a novel alpha‐synuclein positron emission tomography (PET) tracer for the diagnosis of synucleinopathies. Alzheimer s & Dementia. 16(S5). 5 indexed citations
8.
Kroth, Heiko, Felix Oden, Jérôme Molette, et al.. (2019). Discovery and preclinical characterization of [18F]PI-2620, a next-generation tau PET tracer for the assessment of tau pathology in Alzheimer’s disease and other tauopathies. European Journal of Nuclear Medicine and Molecular Imaging. 46(10). 2178–2189. 134 indexed citations
9.
Mueller, André, Heiko Kroth, Hanno Schieferstein, et al.. (2017). [P2–381]: PRECLINICAL CHARACTERIZATION OF PI‐2620, A NOVEL TAU PET TRACER FOR DETECTION OF TAU IN AD AND OTHER TAUOPATHIES. Alzheimer s & Dementia. 13(7S_Part_15). 6 indexed citations
10.
Mueller, André, Heiko Kroth, Hanno Schieferstein, et al.. (2017). [IC‐P‐192]: PRECLINICAL CHARACTERIZATION OF PI‐2620, A NOVEL TAU PET TRACER FOR DETECTION OF TAU IN AD AND OTHER TAUOPATHIES. Alzheimer s & Dementia. 13(7S_Part_3). 2 indexed citations
11.
Molette, Jérôme, Nada Abla, Dominique Besson, et al.. (2013). Identification and Optimization of an Aminoalcohol-Carbazole Series with Antimalarial Properties. ACS Medicinal Chemistry Letters. 4(11). 1037–1041. 37 indexed citations
12.
Roberts, Lee R., Paul A. Bradley, Mark E. Bunnage, et al.. (2011). Acidic triazoles as soluble guanylate cyclase stimulators. Bioorganic & Medicinal Chemistry Letters. 21(21). 6515–6518. 22 indexed citations
13.
14.
Médebielle, Maurice, Jérôme Molette, Emilie David, et al.. (2008). Copper catalyzed 1,3-dipolar cycloaddition reaction of azides with N-(2-trifluoroacetylaryl)propargylamines. Journal of Fluorine Chemistry. 129(9). 788–798. 6 indexed citations
15.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Daniel K. Cashion Breakdown of academic impact, for papers by Yvan Varisco Breakdown of academic impact, for papers by Selena Milicevic Sephton Breakdown of academic impact, for papers by Natalie Beschörner Breakdown of academic impact, for papers by Kaleigh F. Roberts Breakdown of academic impact, for papers by Akihiko Fujikawa Breakdown of academic impact, for papers by Hiroshi Shimadzu Breakdown of academic impact, for papers by Mònica Aparici Breakdown of academic impact, for papers by José-Ignacio Andrés Breakdown of academic impact, for papers by Efthymia Vokali
Rankless by CCL
2026